Latest market price
128.95
-1.96-1.50%
OverviewShort InterestFilings
HALOQT75Halozyme Therapeutics, Inc.·NASDAQ
128.95-1.50%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 08, 20264Statement of changes in beneficial ownership
Oct 08, 20264/AStatement of changes in beneficial ownership (amended)
Oct 02, 20263Initial statement of beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Sep 30, 20268-KCurrent report
Sep 22, 20268-KCurrent report
Sep 18, 20268-KCurrent report
Sep 17, 20264Statement of changes in beneficial ownership
Sep 16, 20268-KCurrent report
Sep 11, 20264Statement of changes in beneficial ownership
Sep 02, 20264Statement of changes in beneficial ownership
Aug 21, 20263Initial statement of beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 18, 20268-KCurrent report
Aug 11, 20264Statement of changes in beneficial ownership
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 09, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20268-KCurrent report
Jul 02, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
#1 / 25 of 358
Page
▼
/ 15